Stroke
From the Journals
Study points to causal role for Lp(a) in atrial fibrillation
The relation is relatively modest but strongly argues for increased testing of Lp(a) and adding atrial fibrillation as a secondary outcome to...
Latest News
Real-world data suggest coprescribing PDE5 inhibitors and nitrates may be safe
There is a scarcity of real-world data showing that using the two types of drugs together increase cardiovascular risks, according to researchers...
From the Journals
Bariatric surgery cuts cardiovascular events, even in seniors
In persons with obesity, even those aged 65-75 years of age, bariatric surgery can reduce long-term cardiovascular events, such as heart failure,...
Conference Coverage
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class...
Conference Coverage
SCORED: Sotagliflozin shows robust MACE benefit
Trial results in patients with diabetes, CKD, and high CVD risk showed robust benefits across MACE outcomes, distinguishing sotagliflozin from the...
From the Journals
Drugs used for nausea/vomiting linked to stroke risk
From the Journals
Even light drinking ups CV risk; harm rises along with intake
All levels of alcohol intake are harmful with regard to cardiovascular disease, and the risk increases exponentially as alcohol intake rises, even...
Conference Coverage
Hybrid ACC 2022 resurrects the live scientific session
The ACC offers a traditional in-person meeting spanning all of cardiology paired with what could be a lasting legacy of the pandemic, a robust,...
Guidelines
New guidance on palliative care for neurologic disorders
Palliative care includes much more than hospice services, according to a new guideline.
Feature
Death of pig heart transplant patient is more a beginning than an end
The landmark case will have much to teach; still, it “turns back the clock” to a time when immunosuppression was especially intense “because we...
Conference Coverage
Real-world data support safety of newer LAA device
More than 18 months after approval, the Watchman FLX left atrial appendage closure device is performing well at 45 days in real-world use.